Skip to main content

Table 3 Baseline ORM related to menstrual outcome 6 months after CTX group of anovulatory patients (oligomenorrheic and amenorreic) and group of ovulatory patients (eumenorrheic)

From: Age, anti-müllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide

 

Eumenorrhea (n = 19)

Oligomenorrhea + Amenorrhea (n = 28)

Age (years)

32.9 ± 3.5

36.5 ± 3.8*

AMH (ng/mL)

5.34 (2.71–8.15)

1.31 (0.72 – 2.89)**

AFC (follicles)

13.5 (11–16)

9 (7.75–12)**

  1. Oligomenorrhea + Amenorrhea X Eumenorrhea (Regular cycles): *p = 0.02; **p < 0.001